findmyKOL

Charles Athill, MD

Enriched profile

Cardiac Electrophysiologist · San Diego Cardiac Center

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 San Diego, CA · West · United StatesSpecialtyClinical Cardiac ElectrophysiologyFocusCardiac Arrhythmias and Treatments+4
Active KOLfindmyKOL type: EliteLatest publication2024Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Charles Athill is Cardiac Electrophysiologist at San Diego Cardiac Center. OpenAlex indexes 41 publications with 1,304 citations (h-index 16); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 16 Oct 2026

Overview

Updated 16 Oct 2026

Charles Athill, M.D., is Cardiac Electrophysiologist at San Diego Cardiac Center. The public record shows 41 publications with 1,304 citations (h-index 16), centered on Cardiac Arrhythmias and Treatments, Atrial Fibrillation Management and Outcomes, Cardiac pacing and defibrillation studies. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 38 companies.

  • Most recent indexed publication: 2024 · Circulation
  • Top research focus: Cardiac Arrhythmias and Treatments
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 38 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Atrial Fibrillation2 trialsArrhythmias, Cardiac1 trial

Research focus

OpenAlex concept fingerprint
Cardiac Arrhythmias and TreatmentsAtrial Fibrillation Management and OutcomesCardiac pacing and defibrillation studiesCardiac electrophysiology and arrhythmiasNonlinear Dynamics and Pattern Formation

Drugs & molecules

across trials, industry payments and publications
Verquvogeneric · VericiguatClinical trials—Industry payments17Publications—Entrestogeneric · Sacubitril / valsartanClinical trials—Industry payments10Publications—Rybelsusgeneric · SemaglutideClinical trials—Industry payments10Publications—Leqviogeneric · InclisiranClinical trials—Industry payments8Publications—Andexxageneric · Andexanet alfaClinical trials—Industry payments7Publications—Eliquisgeneric · ApixabanClinical trials—Industry payments6Publications—Xareltogeneric · RivaroxabanClinical trials—Industry payments6Publications—Amvuttrageneric · VutrisiranClinical trials—Industry payments5Publications—Jardiancegeneric · EmpagliflozinClinical trials—Industry payments4Publications—Nexletolgeneric · Bempedoic acidClinical trials—Industry payments3Publications—Camzyosgeneric · MavacamtenClinical trials—Industry payments2Publications—Injectafergeneric · Ferric carboxymaltoseClinical trials—Industry payments2Publications—

Works with

trial sponsors and companies reporting payments
Biosense Webster, Inc.Clinical trials2Industry payments147Abbott LaboratoriesClinical trials—Industry payments132Boston Scientific CorporationClinical trials—Industry payments87ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Clinical trials—Industry payments50Medical Device Business Services, Inc.Clinical trials—Industry payments23Novartis Pharmaceuticals CorporationClinical trials—Industry payments17Merck Sharp & Dohme LLCClinical trials—Industry payments11AstraZeneca Pharmaceuticals LPClinical trials—Industry payments8Alnylam Pharmaceuticals Inc.Clinical trials—Industry payments7Janssen Pharmaceuticals, IncClinical trials—Industry payments6Cardiva Medical, Inc.Clinical trials—Industry payments5CVRx, Inc.Clinical trials—Industry payments5E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments5Novo Nordisk IncClinical trials—Industry payments5Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments4Kestra Medical Technology Services, Inc.Clinical trials—Industry payments4Medtronic, Inc.Clinical trials—Industry payments4Esperion Therapeutics, Inc.Clinical trials—Industry payments3Heartflow, Inc.Clinical trials—Industry payments3iRhythm Technologies, Inc.Clinical trials—Industry payments3Pfizer Inc.Clinical trials—Industry payments3Acutus Medical, Inc.Clinical trials—Industry payments2Amgen Inc.Clinical trials—Industry payments2Cleerly, Inc.Clinical trials—Industry payments2Daiichi Sankyo Inc.Clinical trials—Industry payments2Philips Electronics North America CorporationClinical trials—Industry payments2ShockWave Medical, IncClinical trials—Industry payments2AbiomedClinical trials—Industry payments1AltaThera Pharmaceuticals LLCClinical trials—Industry payments1Bardy Diagnostics, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
41publications

Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.

1,304citations

Total citations across indexed works.

16h-index

Hirsch index (OpenAlex). i10-index 17.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
38companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

38 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    73.3%
    Beta blocker27.5%
    Metoprolol Succinate48%Metoprolol Tartrate24%Sotalol17%Carvedilol11%
    Part D≥62 patients
    Antiarrhythmic18.9%
    Flecainide Acetate36%Amiodarone Hcl25%Dofetilide24%Multaq14%
    Part D≥32 patients

    + 9 more classes in this area

  • Blood & clotting

    25.5%
    Factor Xa inhibitor24.6%
    Eliquis61%Xarelto39%
    Part D≥54 patients
    P2Y12 inhibitor0.9%
    Clopidogrel100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    1.2%
    SGLT2 inhibitor1.2%
    Jardiance100%
    Part D<11 patients
Where care is delivered (Part B)18.9% facility · 81.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 16 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Andrea Natale13Hrayr S. Karagueuzian11Daniel P. Melby10Annie Ruppert9Christopher Joseph8Anshul M. Patel8Masaaki Yashima7JASON D. ZAGRODZKY7Young‐Hoon Kim7Luigi Di Biase6Peng‐Sheng Chen6Francis E. Marchlinski6Erik Benjamin Kulstad6Craig Delaughter6José Osorio6Mark D. Metzl6Philip J. Gentlesk5George Monir5Hugh G Calkins5Takanori Ikeda5Danya Willms5David C. Willms5SHANE M. BAILEY5Kenneth A. Ellenbogen5Jose Nazari5James N. Weiss4James D. Daniels4Julie Cooper4MOUSSA C. MANSOUR4Vivek Yerrapu Reddy4Tsu‐Juey Wu4Tsu-Juey Wu4G Francisco4Ambrose Panico3Michael C. Fishbein3Samuel Omotoye3Srinivas Rao Dukkipati3Robert Fishel3Alan Garfinkel3Brian DeVille3

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/charles-athill-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    sandiegomagazine.com/partner-content/faces-of-healthcare-2025-san-diego-cardiac-center-2

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sandiegomagazine.com ↗
  • Other

    sharp.com/health-news/honoring-his-father-through-dedicated-heart-care

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sharp.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Fellow

    American College of Cardiology (FACC)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sandiegomagazine.com ↗
  • Fellow

    Heart Rhythm Society (FHRS)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sandiegomagazine.com ↗

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.